Suppr超能文献

[流式细胞术在甲状旁腺增生和腺瘤研究中的应用]

[The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].

作者信息

Mangili F, Sassi I, Schiaffino E, Zogno C, Cantaboni A, Schmid C

机构信息

Cattedra di Anatomia Patologica, Istituto Scientifico H San Raffaele di Milano.

出版信息

Pathologica. 1992 Jul-Aug;84(1092):459-65.

PMID:1491887
Abstract

To discriminate benign from malignant parathyroid glands lesions is often difficult, because the morphologic features lack absolute diagnostic value. The differential diagnosis between chief cell hyperplasia and parathyroid adenoma is frequently based on physical features such as increased gland weight and number of enlarged glands. A carcinoma is identified by the evidence of local invasion, metastases or recurrence. Nevertheless the lesions classified as benign for lack of histologic features of aggressiveness can show nuclear atypia, increased mitotic figures and broad fibrous bands. Since DNA aneuploidy is present in a great number of human neoplasms and DNA aneuploidy has been suggest to be a marker of malignancy, flow cytometric assessment of ploidy appeared a possible method for rapid and objective distinction between benign and malignant lesions. Flow cytometric DNA content was evaluated on 113 parathyroid glands: the parathyroids were resected from 26 patients with hyperparathyroidism and from 17 patients with adenoma. The analysis was performed on paraffin-embedded specimens according to Hedley with minor modifications. Interpretable histograms were obtained for 103 parathyroids gland (mean CV = 5.3). Aneuploidy was detected in 22.5% of glands; in 12 instances of parathyroid hyperplasia the glands of the same patient showed different DNA Indexes. Cytometric results and morphological features do not correlate as far as aneuploidy and cellular atypia are involved. Although our results fail to show any correlation between morphology of parathyroid cells and DNA content, and abnormal DNA content suggests a careful follow up of these patients.

摘要

区分甲状旁腺的良性与恶性病变往往很困难,因为形态学特征缺乏绝对的诊断价值。主细胞增生与甲状旁腺腺瘤之间的鉴别诊断常常基于一些物理特征,如腺体重量增加和肿大腺体的数量。癌则通过局部侵犯、转移或复发的证据来确定。然而,那些因缺乏侵袭性组织学特征而被归类为良性的病变可能会表现出核异型性、有丝分裂象增加和宽纤维带。由于大量人类肿瘤中存在DNA非整倍体,并且DNA非整倍体被认为是恶性肿瘤的一个标志物,因此流式细胞术评估倍性似乎是一种快速、客观地区分良性和恶性病变的可能方法。对113个甲状旁腺进行了流式细胞术DNA含量评估:这些甲状旁腺取自26例甲状旁腺功能亢进患者和17例腺瘤患者。根据Hedley的方法并做了少许修改,对石蜡包埋标本进行了分析。103个甲状旁腺获得了可解释的直方图(平均变异系数 = 5.3)。在22.5%的腺体中检测到非整倍体;在12例甲状旁腺增生病例中,同一患者的腺体显示出不同的DNA指数。就非整倍体和细胞异型性而言,细胞计数结果与形态学特征不相关。尽管我们的结果未能显示甲状旁腺细胞形态与DNA含量之间有任何关联,但DNA含量异常提示对这些患者要进行仔细随访。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验